Table 1.

Objective response rates (ORRs) collection of 18 cancer types.

Tumor types	Abbreviation	ORR (literature)
Adrenocortical carcinoma	ACC	0.06 (Le Tourneau et al., 2017)
Bladder urothelial carcinoma	BLCA	0.182 (Rosenberg et al., 2016; Apolo et al., 2017; Bellmunt et al., 2017; Powles et al., 2017; Sharma et al., 2017)
Breast invasive carcinoma	BRCA	0.052 (Dirix et al., 2018)
Cervical squamous cell carcinoma and endocervical adenocarcinoma	CESC	0.208 (Hollebecque et al., 2017)
Esophageal carcinoma	ESCA	0.112 (Chung et al., 2016; Fuchs et al., 2017)
Glioblastoma multiforme	GBM	0.08 (Reardon et al., 2017a; Reardon et al., 2017b)
Head and neck squamous cell carcinoma	HNSC	0.16 (Ferris et al., 2016; Bauml et al., 2017)
Kidney renal clear cell carcinoma	KIRC	0.25 (Motzer et al., 2015)
Liver hepatocellular carcinoma	LIHC	0.2 (El-Khoueiry et al., 2017; Wainberg et al., 2017)
Lung adenocarcinoma	LUAD	0.19 (Borghaei et al., 2015)
Lung squamous cell carcinoma	LUSC	0.2 (Brahmer et al., 2015)
Mesothelioma	MESO	0.167 (Scherpereel et al., 2017)
Ovarian serous cystadenocarcinoma	OV	0.097 (Brahmer et al., 2012; Hamanishi et al., 2015; Disis et al., 2016)
Pancreatic adenocarcinoma	PAAD	0 (Brahmer et al., 2012)
Sarcoma	SARC	0.11 (Dangelo et al., 2017; Tawbi et al., 2017)
Skin cutaneous melanoma	SKCM	0.387 (Larkin et al., 2015; Robert et al., 2015)
Uterine corpus endometrial carcinoma	UCEC	0.13 (Fleming et al., 2017)
Uveal melanoma	UVM	0.036 (Algazi et al., 2016)